Novel simultaneous combination chemical thrombolysis/rheolytic thrombectomy therapy for acute critical limb ischemia: The power-pulse spray technique

被引:57
作者
Allie, DE
Hebert, CJ
Lirtzman, MD
Wyatt, CH
Keller, VA
Khan, MH
Barker, EA
McElderry, MW
Khan, MA
Fail, PS
Stagg, SJ
Mitran, EV
Chaisson, G
Allie, SD
Allie, AA
Walker, CM
机构
[1] Cardiovasc Inst, Lafayette, LA USA
[2] Cardiovasc Inst, Houma, LA USA
[3] SW Med Ctr, Lafayette, LA USA
[4] Opelousas Gen Hosp, Opelousas, LA USA
[5] Terrebonne Gen Med Ctr, Houma, LA USA
[6] Terrebonne Gen Med Ctr, S Opelousas, LA USA
关键词
vascular interventions; catheterization; iliac; superficial femoral procedure; percutaneous transluminal angioplasty; stent;
D O I
10.1002/ccd.20216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The novel power-pulse spray (P-PS) technique maximizes and combines the advantages and minimizes the disadvantages of both chemical thrombolysis (CT) and rheolytic thrombectomy (RT). Forty-nine consecutive patients with iliofemoral thrombotic occlusion were treated via P-PS technique. Using a 6 Fr RT catheter, saline prime was exchanged for thrombolytic solution [group 1, 10-20 mg tenecteplase (TNK)/50 cc saline, n = 25; group 2, 1,000,000 urokinase (UK)/50 cc saline, n = 24]. The outflow port was closed, then the catheter was advanced at 1 mm increments while pulsing lytic agent. After 30-min lysis time, RT and definitive treatment of the underlying stenosis were performed. Procedure success was 23/25 (92%) and 22/24 (91.6%) for group I and 2, respectively. The mean total procedure time was 72 and 75 min in group 1 and 2, respectively. Thirty-day limb salvage was 91% in both groups. There were no major surgical complications. The P-PS technique is safe and effective using either UK or TNK, offering several potential advantages over monotherapy, including more rapid revascularization, decreases systemic lytic exposure and bleeding complications while facilitating both CT and RT capacity and efficacy. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:512 / 522
页数:11
相关论文
共 37 条
  • [1] Allie David E, 2003, J Invasive Cardiol, V15, P334
  • [2] Almeda Francis Q, 2002, Cardiovasc Radiat Med, V3, P12, DOI 10.1016/S1522-1865(02)00146-4
  • [3] ADJUNCTIVE THROMBOLYTIC THERAPY DURING ANGIOPLASTY FOR ISCHEMIC REST ANGINA - RESULTS OF THE TAUSA TRIAL
    AMBROSE, JA
    ALMEIDA, OD
    SHARMA, SK
    TORRE, SR
    MARMUR, JD
    ISRAEL, DH
    RATNER, DE
    WEISS, MB
    HJEMDAHLMONSEN, CE
    MYLER, RK
    MOSES, J
    UNTERECKER, WJ
    GRUNWALD, AM
    GARRETT, JS
    COWLEY, MJ
    ANWAR, A
    SOBOLSKI, J
    [J]. CIRCULATION, 1994, 90 (01) : 69 - 77
  • [4] Ansel GM, 2002, J ENDOVASC THER, V9, P395, DOI 10.1583/1545-1550(2002)009<0395:RTITMO>2.0.CO
  • [5] 2
  • [6] Armon MP, 1997, BRIT J SURG, V84, P47
  • [7] BAISDELL FW, 1978, J VASC SURG, V84, P822
  • [8] COLLEN D, 1994, THROMB HAEMOSTASIS, V72, P98
  • [9] FUNCTIONAL-PROPERTIES OF A PROTOTYPE RHEOLYTIC CATHETER FOR PERCUTANEOUS THROMBECTOMY - IN-VITRO INVESTIGATIONS
    DOUEK, PC
    GANDJBAKHCHE, A
    LEON, MB
    BONNER, RF
    [J]. INVESTIGATIVE RADIOLOGY, 1994, 29 (05) : 547 - 552
  • [10] GRAOR RA, 1994, ANN SURG, V220, P251